Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cédric Miolane"'
Autor:
Vincent Jannin, Fiona McCartney, Cédric Miolane, Nicolas Ritter, Frédéric Demarne, Delyan R. Hristov, Hakime Boulghobra, David J. Brayden, Yann Chavant, Stéphanie Chevrier
Publikováno v:
Journal of Controlled Release. 310:115-126
Labrasol® ALF (Labrasol®), is a non-ionic surfactant excipient primarily used as a solubilising agent. It was investigated here as an intestinal permeation enhancer in isolated rat colonic mucosae in Ussing chamber and in rat in situ intestinal ins
Autor:
Cédric Miolane, Vincent Jannin, Véronique Préat, Hatem Fessi, Ana Beloqui, Sandrine Bourgeois, Camille Dumont
Publikováno v:
International journal of pharmaceutics, Vol. 586, p. 119581 (2020)
Peptides are therapeutic molecules with high potential to treat a wide variety of diseases. They are large hydrophilic compounds for which absorption is limited by the intestinal epithelial border covered by mucus. This study aimed to evaluate the po
Autor:
Sébastien Urbaniak, Cédric Miolane, Quentin Lelong, Vincent Jannin, Jean-Pierre Valour, Hatem Fessi, Camille Dumont, Sandrine Bourgeois
Publikováno v:
Journal of Drug Delivery Science and Technology. 54:101394
The aim of the study was to develop a protocol to encapsulate lipidized-peptides in Nanostructured Lipid Carrier (NLC) by High Pressure Homogenization (HPH) for oral delivery. The impact of composition, pressure and number of cycles on particle size,
Autor:
Cédric Miolane, Frédéric Demarne, Vincent Jannin, Lucia Blas, Stéphanie Chevrier, Denis Spitzer
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 111
Objective To evaluate the digestibility of Solid Lipid Nanoparticles (SLN) of glyceryl dibehenate prepared either with surfactants by ultrasonication or without surfactant by spray-flash evaporation. Methods SLN of glyceryl dibehenate (Compritol® 88
Publikováno v:
Drug Development and Industrial Pharmacy. 38:1068-1076
Sustained-release mini-tablets are a potentially suitable for paediatric drug delivery or as multi-particulate dosage forms.To evaluate the potential for developing lipophilic matrix mini-tablets and to assess the effects of Compritol® 888 ATO conce
Publikováno v:
Drug development and industrial pharmacy. 41(10)
Niacin (vitamin B3) is a micronized active pharmaceutical ingredient (API) with poor flow properties making the production of high-dose sustained-release tablets by direct compression a challenge.We evaluated various wet granulation processes as a si
Autor:
Rosiaux, Yvonne1 (AUTHOR) yrosiaux@gattefosse.com, Girard, Jean-Michel1 (AUTHOR), Desvignes, Florence1 (AUTHOR), Miolane, Cédric1 (AUTHOR), Marchaud, Delphine1 (AUTHOR)
Publikováno v:
Drug Development & Industrial Pharmacy. Oct2015, Vol. 41 Issue 10, p1738-1744. 7p.